Weedie


Home / Newswire

v1.0.0
Home
Stocks
Warrants
Heatmap
Newswire
Shorts
Halts
Licenses

Weedstocks Newswire Feed

Weedstocks news RSS feed

CannaRoyalty Acquires Rights to Innovative Infused Pre-Roll Brand, Pacific Remedy

2018-07-12 07:00:00

OTTAWA, July 12, 2018 /CNW/ - CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) ("CannaRoyalty" or the "Company"), a leading North American cannabis products and brands company, announced today that it has acquired the exclusive rights to distribute and manufacture Pacific Remedy LLC's ("Pacific Remedy") industry-leading infused pre-rolls in California (the "Agreement"). The Agreement also provides CannaRoyalty with the option to purchase global brand rights (the "Option") for the premium infused pre-roll manufacturer.

"Brands are true value. Built through real consumer trust. They are our mission," said Marc Lustig, Chairman & CEO, CannaRoyalty.

"I founded this company over 3 years ago with a vision that brands would dominate the future of the cannabis industry. Brands represent the trust relationship formed through repeat sales to, and an ongoing conversation with, a consumer. Most jurisdictions, including our home jurisdiction of Canada, do not yet provide the right conditions for that trust to form. Conversely, I have found that there is no better place in the world than California to create that trust, which is why we are there; building the pre-eminent global cannabis brand growth platform."

Pacific Remedy is a California-based brand founded by Timothy Elze and Jon Rivera. Pacific Remedy's uniquely designed infused pre-rolls make them a differentiated manufacturer in the premium pre-roll category. In 2017, Pacific Remedy's products were carried in 13 cannabis dispensaries throughout the Bay Area and Southern California. Subsequent to this Agreement, Pacific Remedy will be able to sell its premium product through CannaRoyalty's distribution network, which covers the majority of California's approximately 500 licensed dispensaries.

...

Read more


Auxly Announces Director Resignation

2018-07-12 07:00:00

VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) ("Auxly" or the "Company") has announced today that following his appointment as Chief Executive Officer of a federal agency, Invest in Canada, Ian McKay has resigned as a director of the Company’s Board of Directors. The Company has initiated a search for a new director to replace Mr. McKay.

Chuck Rifici, Chairman and Chief Executive Officer of Auxly Cannabis Group commented, “On behalf of the Board of Directors and the Auxly team, I'd like to thank Ian for his valuable guidance and support over the past year. We wish him well in this exciting phase of public service. In my opinion, there's no one better than Ian to launch this agency and promote Canada as a premier destination for foreign direct investment.  Our loss is Canada's gain."

ON BEHALF OF THE BOARD "Chuck Rifici" Chairman & CEO

About Auxly Cannabis Group Inc. (TSX.V:XLY)

Auxly Cannabis Group is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.

...

Read more


HEXO Announces Stock Option Grants to Directors, Officers and Employees

2018-07-11 19:34:00

GATINEAU, Quebec, July 11, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation ("HEXO" or the "Company") (TSX:HEXO) announces that it has made a grant of stock options under its stock option plan to certain of its directors and officers to acquire a total of 4,325,000 common shares of the Company. In addition, the Company has granted options to acquire an aggregate of 1,366,500 common shares of the Company to certain non-executive employees. All of the options are exercisable at a price of $4.89 per share. One-third of the options will vest on the one year anniversary of the date of grant and the balance will vest quarterly over two years thereafter. The options have a term of 10 years and are subject in all respects to the terms of HEXO's stock option plan and the requirements of the TSX.

“HEXO is pleased to be able to use this opportunity to provide all employees with stock options, allowing them to become owners as we continue to grow and prepare for the adult use market.  We’d like to thank them for their support and hard work over the last 5 years in helping us get to this stage in our growth” said Sebastien St-Louis, co-founder and CEO of HEXO.

About HEXO

HEXO creates and distributes innovative, easy-to-use and easy-to-understand products to serve the Canadian cannabis market. One of the country’s lowest-cost producers, HEXO is rapidly increasing its production capacity in the lead up to the adult-use cannabis market. The Company currently operates with 300,000 sq. ft. of production capacity and has another 1,000,000 sq. ft. expansion set to be complete by year end. HEXO will serve the adult-use market under the HEXO brand, while continuing to serve its medical cannabis clients through the well-known Hydropothecary brand.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

...

Read more


HEXO annonce l'octroi d'options d'achat d'actions à ses administrateurs, dirigeants et employés

2018-07-11 19:34:00

GATINEAU, Québec, 11 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO)  annonce qu'en vertu de son régime d'options d'achat d'actions, elle a accordé des options d'achat d'actions à certains de ses administrateurs et dirigeants pour leur permettre d'acquérir un total de  4 325 000 d’actions ordinaires de la Société. De plus, la Société a accordé à certains employés non cadres des options en vue d'acquérir un total de 1 366 500 de ses actions ordinaires. Toutes les options sont exerçables au prix de 4,89 $ par action. Un tiers des options seront acquises à l'anniversaire d'un an à compter de la date d'attribution, et le solde sera acquis trimestriellement sur une période de deux ans par la suite. Les options ont une durée de 10 ans et sont soumises à tous égards aux dispositions du régime d'options d'achat d'actions de HEXO et aux exigences de la TSX.

« Chez HEXO, nous sommes heureux de pouvoir profiter de cette occasion pour offrir à tous les employés des options d'achat d'actions, ce qui leur permet de devenir propriétaires au fur et à mesure que nous poursuivons notre croissance et que nous nous préparons pour le marché pour les adultes. Nous tenons à les remercier pour leur soutien et leur travail acharné au cours des cinq dernières années et de nous avoir aidé à atteindre ce stade de notre croissance », a déclaré Sébastien St-Louis, cofondateur et PDG de HEXO.

À propos de Hexo HEXO crée et distribue des produits novateurs, faciles à utiliser et à comprendre pour servir le marché canadien du cannabis. L'un des producteurs les moins chers au pays, HEXO augmente rapidement sa capacité de production dans la perspective du marché du cannabis chez les adultes. La Société exploite actuellement une capacité de production de 300 000 pieds carrés et a un autre agrandissement de 1 000 000 pieds carrés qui devrait être terminé d'ici la fin de l'année. HEXO desservira le marché de l'usage adulte sous la marque HEXO, tout en continuant à servir ses clients du cannabis médical par l'entremise de la célèbre marque Hydropothecary.

La Bourse de  Toronto TSX et son fournisseur de services de réglementation (au sens attribué à ce terme dans les politiques de la Bourse de Toronto TSX) n’assument aucune responsabilité quant à la pertinence ou à l’exactitude du présent communiqué.

Relations avec les investisseurs Jennifer Smith Gestionnaire des rapports financiers et des relations avec les investisseurs 1-866-438-THCX (8429) invest@thehydropothecary.com  www.THCX.com

...

Read more


Invictus Secures Supply Agreement with British Columbia Liquor Distribution Branch

2018-07-11 17:00:19

VANCOUVER, July 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has signed a Memorandum of Understanding ("MOU") with the BC Liquor Distribution Branch ("LDB") to supply the province with a selection of premium cannabis products for the upcoming recreational marketplace. Invictus' portfolio includes award-winning strains, supplied by our wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), located in Alberta.

"As a company with operations in BC, Invictus is immensely proud to have been selected to provide the LDB with quality cannabis products ahead of legalization on October 17, 2018," said Dan Kriznic, Chairman and CEO of Invictus. "We are looking forward to a partnership that will work to achieve our mutual objectives of building a safer marketplace for cannabis, while spurring economic activity here at home."

Beyond supply agreements, Invictus is working to develop and implement a strategic patient acquisition program aimed at winning market share for medical cannabis sales, in addition to its ambitious retail plan that involves establishing dispensaries across Western Canada. At the same time, Invictus is taking measured steps to expand our cultivation space and strain profile, as demand in the adult recreational market continues to grow.

The MOU with BC's LDB is the Company's first provincial supply agreement to service the adult-use market and falls in line with our multi-faceted sales and distribution strategy.

For more information, please visit www.invictus-md.com.

...

Read more


B.C. Selects THC BioMed to Supply Recreational Adult-Use Cannabis

2018-07-11 15:00:19

THC.CSETHCBF - OTCTFHC.F

VANCOUVER, July 11, 2018 /CNW/ - THC BioMed Intl Ltd. ("THC" or the "Company") (CSE:THC) announces that it has been selected by the province to supply British Columbians with adult-use cannabis. THC has entered into an agreement through its wholly-owned subsidiary, THC BioMed Ltd. to supply non-medical cannabis to the B.C. Liquor Distribution Branch following legalization.

THC is very proud to be given this opportunity to have its products available for sale in British Columbia, beginning October 17, 2018.

In the supply agreement, B.C. agrees to purchase approximately 2,390,200 grams of cannabis from THC in the first 12 months of legalization at the prices set by the province. The cannabis will be in 19 different products and in the form of dried flower, pre-rolled and oil.

"This supply agreement cements our entry into the adult-use recreational market. For THC it brings a fundamental change as we now begin to exhibit our true strengths, allowing the business to grow organically," said John Miller, President and CEO of THC, "We look forward to providing adult Canadians with an exceptional product."

...

Read more


Maricann Announces Third Consecutive Provincial Win - Signs MOU with BC Liquor Distribution Branch

2018-07-11 14:35:00

TORONTO, July 11, 2018 (GLOBE NEWSWIRE) -- Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCQB:MRRCF) (“Maricann” or the “Company”) is pleased to announce that it has been selected by the BC Liquor Distribution Branch (“BCLDB”) to enter into a memorandum of understanding (“MOU”) as a preferred licensed producer to initially supply approximately 3,621,900g (~3,622kg) of non-medical cannabis to BCLDB over the first 12 months following legalization.

Highlights

“Maricann is excited to enter into this MOU with BCLDB, and we are proud to work with them as a partner in this exciting launch phase,” said Geoff Kosar, Vice President Sales & Marketing, Maricann Group Inc.

For more information, visit the provincial government’s media channel at www.news.gov.bc.ca and on www.bclbcannabisupdates.com, where a complete list of licensed producers will be available.

About Maricann Group Inc.

...

Read more


HEXO reaches supply agreement with BC’s Liquor Distribution Branch

2018-07-11 14:30:00

GATINEAU, Quebec, July 11, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is proud to announce that it has entered into a memorandum of understanding with British Columbia’s Liquor Distribution Branch (BCLDB).

Under the deal, the Company will supply the province with its award-winning Elixir products, a line of easy-to-use, discreet  sublingual cannabis oil sprays. Elixir will be available in formulations of THC, CBD or  a 1:1 ratio in peppermint oil and introducing a natural cannabis taste in a medium-chain triglyceride (MCT) oil. Elixir is kosher-certified, gluten-free and will be available in a 15ml childproof spray bottle.

“We welcome the opportunity to partner with the Liquor Distribution Branch in British Columbia, a province that has always been at the forefront of cannabis culture in Canada. We are very proud that our smoke-free products will now be available in a province known for a health-conscious and outdoor lifestyle,” said Sebastien St-Louis, co-founder and CEO of HEXO.

About HEXO

HEXO creates and distributes innovative, easy-to-use and easy-to-understand products to serve the Canadian cannabis market. One of the country’s lowest-cost producers, HEXO is rapidly increasing its production capacity in the lead up to the adult-use cannabis market. The Company currently operates with 300,000 sq. ft. of production capacity and has another 1,000,000 sq. ft. expansion set to be complete by year end. HEXO will serve the adult-use market under the HEXO brand, while continuing to serve its medical cannabis clients through the well-known Hydropothecary brand.

...

Read more


HEXO conclut une entente d’approvisionnement avec la Direction de la distribution des alcools de la C.-B.

2018-07-11 14:30:00

GATINEAU, Québec, 11 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) est fière d’annoncer qu’elle a conclu un protocole d’entente avec Direction de la distribution des alcools de la Colombie-Britannique.

En vertu de l’entente, la Société fournira à la province ses produits primés de la gamme Elixir qui comprend trois vaporisateurs sublinguaux d’huile de cannabis, discrets et faciles à utiliser. Elixir sera offert en formulations de THC, de CBD ou d’une combinaison 1:1 dans une huile de menthe poivrée ou une huile comestible de triglycéride à chaîne moyenne (TCM). Disponibles dans un contenant de 15 ml à l’épreuve des enfants, ces produits sont certifiés casher et sans gluten.

« Nous sommes heureux de pouvoir collaborer avec la Direction de la distribution des alcools de la Colombie-Britannique, une province qui a toujours été à la pointe de la culture du cannabis au Canada, a déclaré Sébastien St-Louis, cofondateur et PDG d’HEXO. Nous sommes très fiers que nos produits sans fumée soient maintenant disponibles dans une province reconnue pour son mode de vie sain et axé sur les activités de plein air. »

À propos de Hexo

HEXO crée et distribue des produits novateurs, faciles à utiliser et à comprendre pour servir le marché canadien du cannabis. L'un des producteurs les moins chers au pays, HEXO augmente rapidement sa capacité de production dans la perspective du marché du cannabis chez les adultes. La Société exploite actuellement une capacité de production de 300 000 pieds carrés et a un autre agrandissement de 1 000 000 pieds carrés qui devrait être terminé d'ici la fin de l'année. HEXO desservira le marché de l'usage adulte sous la marque HEXO, tout en continuant à servir ses clients du cannabis médical par l'entremise de la célèbre marque Hydropothecary.

...

Read more


Supreme Cannabis Enters Into MOU with BC Liquor Distribution Board

2018-07-11 14:00:31

TORONTO, July 11, 2018 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSXV:FIRE), today announced that the Company's wholly owned subsidiary, 7ACRES, has entered into a memorandum of understanding ("MOU") with the British Columbia Liquor Distribution Board ("BCLDB") to supply recreational cannabis to BC's private cannabis retailers.

Under the terms of the MOU, 7ACRES will supply the BCLDB with 553 kg of cannabis over a 12-month period. All 7ACRES product will be listed in the top-tier brand category in BC – consistent with other provincial supply agreements 7ACRES has signed.

"British Columbia is a bellwether province for the recreational cannabis space – we consider it one of the most informed and discerning consumer markets for cannabis in the country. It is a testament to our brand, culture and our people that we will be listed in the highest brand category in BC," said John Fowler, CEO of Supreme Cannabis.

British Columbia becomes Supreme Cannabis' third provincial recreational partner alongside Manitoba and Alberta. The Company will provide updates on further provincial partners as they become available. With an annual production capacity expected to reach 50,000 kg once the 7ACRES facility is fully operational, the Company is committed to supplying premium-quality cannabis flower to the Canadian recreational market from coast-to-coast.

...

Read more